A detailed history of New York State Common Retirement Fund transactions in United Therapeutics Corp stock. As of the latest transaction made, New York State Common Retirement Fund holds 36,815 shares of UTHR stock, worth $14.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
36,815
Previous 42,327 13.02%
Holding current value
$14.2 Million
Previous $13.5 Million 2.15%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$311.04 - $363.55 $1.71 Million - $2 Million
-5,512 Reduced 13.02%
36,815 $13.2 Million
Q2 2024

Jul 31, 2024

SELL
$228.26 - $319.04 $670,171 - $936,701
-2,936 Reduced 6.49%
42,327 $13.5 Million
Q1 2024

May 07, 2024

SELL
$210.76 - $249.51 $3.68 Million - $4.35 Million
-17,446 Reduced 27.82%
45,263 $10.4 Million
Q4 2023

Feb 01, 2024

BUY
$214.88 - $256.94 $104,861 - $125,386
488 Added 0.78%
62,709 $13.8 Million
Q3 2023

Nov 07, 2023

SELL
$211.82 - $248.24 $2.37 Million - $2.78 Million
-11,189 Reduced 15.24%
62,221 $14.1 Million
Q2 2023

Aug 07, 2023

SELL
$205.19 - $232.99 $131,321 - $149,113
-640 Reduced 0.86%
73,410 $16.2 Million
Q1 2023

May 02, 2023

SELL
$212.99 - $276.17 $3.52 Million - $4.56 Million
-16,527 Reduced 18.25%
74,050 $16.6 Million
Q4 2022

Jan 30, 2023

BUY
$205.95 - $280.43 $901,855 - $1.23 Million
4,379 Added 5.08%
90,577 $25.2 Million
Q3 2022

Nov 08, 2022

SELL
$203.3 - $244.17 $174,838 - $209,986
-860 Reduced 0.99%
86,198 $18 Million
Q2 2022

Aug 04, 2022

BUY
$174.81 - $241.14 $42,828 - $59,079
245 Added 0.28%
87,058 $20.5 Million
Q1 2022

May 05, 2022

SELL
$166.16 - $213.96 $322,184 - $414,868
-1,939 Reduced 2.18%
86,813 $15.6 Million
Q4 2021

Feb 02, 2022

SELL
$184.32 - $216.08 $20,828 - $24,417
-113 Reduced 0.13%
88,752 $19.2 Million
Q3 2021

Nov 02, 2021

SELL
$179.86 - $214.88 $581,307 - $694,492
-3,232 Reduced 3.51%
88,865 $16.4 Million
Q2 2021

Aug 02, 2021

BUY
$170.47 - $211.93 $596,474 - $741,543
3,499 Added 3.95%
92,097 $16.5 Million
Q1 2021

May 11, 2021

BUY
$153.94 - $174.85 $4.42 Million - $5.02 Million
28,700 Added 47.91%
88,598 $14.8 Million
Q4 2020

Feb 08, 2021

SELL
$101.87 - $151.79 $488,976 - $728,592
-4,800 Reduced 7.42%
59,898 $9.09 Million
Q3 2020

Nov 05, 2020

SELL
$99.9 - $121.13 $1.18 Million - $1.43 Million
-11,800 Reduced 15.43%
64,698 $6.53 Million
Q2 2020

Aug 07, 2020

SELL
$92.74 - $125.82 $112,215 - $152,242
-1,210 Reduced 1.56%
76,498 $9.26 Million
Q1 2020

May 06, 2020

SELL
$79.39 - $115.35 $182,597 - $265,305
-2,300 Reduced 2.87%
77,708 $7.37 Million
Q4 2019

Feb 05, 2020

SELL
$78.31 - $95.34 $352,395 - $429,030
-4,500 Reduced 5.32%
80,008 $7.05 Million
Q3 2019

Nov 07, 2019

SELL
$74.85 - $85.99 $3.12 Million - $3.59 Million
-41,700 Reduced 33.04%
84,508 $6.74 Million
Q2 2019

Aug 09, 2019

BUY
$76.06 - $120.81 $66,932 - $106,312
880 Added 0.7%
126,208 $9.85 Million
Q1 2019

May 08, 2019

SELL
$107.15 - $126.84 $1.08 Million - $1.28 Million
-10,100 Reduced 7.46%
125,328 $14.7 Million
Q4 2018

Feb 08, 2019

BUY
$101.4 - $128.73 $4.34 Million - $5.51 Million
42,800 Added 46.21%
135,428 $14.7 Million
Q3 2018

Nov 07, 2018

SELL
$113.81 - $129.46 $1.41 Million - $1.61 Million
-12,410 Reduced 11.81%
92,628 $11.8 Million
Q2 2018

Aug 10, 2018

SELL
$101.14 - $118.31 $859,690 - $1.01 Million
-8,500 Reduced 7.49%
105,038 $11.9 Million
Q1 2018

May 10, 2018

BUY
$107.21 - $151.94 $407,398 - $577,372
3,800 Added 3.46%
113,538 $12.8 Million
Q4 2017

Feb 13, 2018

BUY
$118.58 - $151.28 $194,471 - $248,099
1,640 Added 1.52%
109,738 $16.2 Million
Q3 2017

Nov 06, 2017

SELL
$114.6 - $136.81 $6.57 Million - $7.84 Million
-57,287 Reduced 34.64%
108,098 $12.7 Million
Q2 2017

Aug 11, 2017

BUY
N/A
165,385
165,385 $21.5 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.